Bimatoprost Ophthalmic Solution for Enhanced Eyelash Growth
| Product dosage: 0.3mg | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 1 | $60.24 | $60.24 (0%) | 🛒 Add to cart |
| 2 | $50.20 | $120.47 $100.39 (17%) | 🛒 Add to cart |
| 3 | $43.50 | $180.71 $130.51 (28%) | 🛒 Add to cart |
| 4 | $42.67 | $240.94 $170.67 (29%) | 🛒 Add to cart |
| 5 | $40.16 | $301.18 $200.79 (33%) | 🛒 Add to cart |
| 6 | $38.48 | $361.42 $230.91 (36%) | 🛒 Add to cart |
| 7 | $37.29 | $421.65 $261.02 (38%) | 🛒 Add to cart |
| 8 | $36.39 | $481.89 $291.14 (40%) | 🛒 Add to cart |
| 9 | $34.58 | $542.12 $311.22 (43%) | 🛒 Add to cart |
| 10 | $33.13
Best per bottle | $602.36 $331.30 (45%) | 🛒 Add to cart |
Synonyms | |||
Bimatoprost ophthalmic solution 0.03% represents a significant advancement in the field of dermatological and ophthalmic therapeutics, specifically formulated to address hypotrichosis of the eyelashes. This prostaglandin analog, initially developed for the reduction of intraocular pressure in open-angle glaucoma and ocular hypertension, was serendipitously discovered to possess a profound secondary benefit: the promotion of eyelash growth, thickness, and darkness. Its mechanism of action, while not fully elucidated, is believed to involve the prolongation of the anagen (growth) phase of the eyelash hair cycle and an increase in the percentage of hairs in this productive phase. This topical treatment is prescribed for patients seeking to improve the appearance of their eyelashes by increasing their length, fullness, and darkness, offering a clinically proven, non-surgical aesthetic enhancement. Its application requires strict adherence to a prescribed regimen to maximize efficacy and minimize potential adverse effects.
Features
- Active Ingredient: Bimatoprost 0.03% (0.3 mg/mL)
- Pharmaceutical Form: Sterile, isotonic, buffered ophthalmic solution
- Presentation: Supplied in a multi-dose 3 mL plastic bottle with an integrated sterile applicator
- Mechanism of Action: Synthetic prostaglandin analog, presumed prostanoid FP receptor agonist
- Prescription Status: Rx-only medication
- Primary Indication: Treatment of hypotrichosis of the eyelashes
Benefits
- Clinically proven to significantly increase eyelash prominence, including length, thickness, and darkness.
- Provides a non-invasive alternative to cosmetic procedures like eyelash extensions or tints.
- Results are gradual and natural-looking, typically observed after 2-3 months of consistent use.
- The effects are sustained with continued application but are reversible upon discontinuation of treatment.
- Offers a targeted therapeutic approach with a well-defined and simple application protocol.
- Can improve patient self-esteem and satisfaction with appearance related to eyelash adequacy.
Common use
Bimatoprost ophthalmic solution is exclusively indicated for the topical treatment of hypotrichosis (inadequate or not enough eyelashes). It is applied once nightly, directly to the skin of the upper eyelid margin at the base of the eyelashes using a single-use sterile applicator. It is not intended for application in the eye or to the lower eyelid. Patients use it to achieve cosmetically enhanced eyelashes that are longer, thicker, and darker. Treatment response is not immediate; measurable changes are typically noted within 1-2 months, with full results generally apparent after 3-4 months of daily application.
Dosage and direction
The recommended dosage is one application per day, in the evening, to the skin of the upper eyelid margin. Directions for Use: 1. Before application, ensure your face is clean, makeup is removed, and contact lenses are removed (if applicable). Contact lenses may be reinserted 15 minutes after application. 2. Holding the sterile applicator horizontally, place one drop of the solution on the area of the applicator closest to the tip but not directly on the tip. 3. While looking into a mirror, draw the applicator carefully across the skin of the upper eyelid margin at the base of the eyelashes, starting from the inner part to the outer part of the eyelid. 4. Blot any excess solution beyond the eyelid margin with a tissue. 5. Dispose of the applicator after a single use; do not reuse. 6. Repeat the process for the opposite upper eyelid margin using a new sterile applicator. Avoid allowing the tip of the bottle to contact surrounding structures, fingers, or any other surface to prevent contamination.
Precautions
- Strict aseptic technique is paramount to prevent contamination of the solution, which could lead to serious ocular infections.
- This product is for external use on the skin of the eyelid margin only. It is not an eye drop and should not be applied directly into the eye.
- If any solution enters the eye, it is not expected to cause harm; however, the eye should not be rinsed.
- Patients should be advised that bimatoprost may gradually increase brown pigmentation of the iris (the colored part of the eye). This change, due to increased melanin, is likely to be permanent.
- May cause eyelid skin darkening, which may be reversible upon discontinuation.
- Hair growth may occur in other skin areas that the solution frequently touches. Any excess solution on the skin should be blotted away.
- Patients with intraocular inflammation (e.g., uveitis) or those scheduled for eye surgery should use with caution and under close physician supervision.
Contraindications
Bimatoprost ophthalmic solution is contraindicated in patients with a known hypersensitivity to bimatoprost or any other ingredient in the formulation. A history of severe allergic reaction or anaphylaxis to prostaglandin analogs warrants avoidance of this product.
Possible side effect
The most common side effects, occurring in approximately 3-4% of patients, are eye pruritus (itching), conjunctival hyperemia (eye redness), and skin hyperpigmentation at the application site. Other reported ocular side effects include:
- Dry eye symptoms
- Eye irritation
- Eyelid erythema (redness)
- Foreign body sensation
- Cataract
- Superficial punctate keratitis
- Periorbital and eyelid edema (swelling)
- Allergic conjunctivitis
- Asthenopia (eye strain)
- Increased iris pigmentation (brown discoloration)
- Trichiasis (misdirected eyelash growth)
- Madarosis (eyelash loss) – typically upon discontinuation of treatment
Drug interaction
Formal drug interaction studies have not been conducted with topical ocular bimatoprost. However, the concomitant use of two or more prostaglandin analogs, or prostaglandin analog prodrugs, is not recommended as it may decrease the efficacy of intraocular pressure-lowering medications or potentiate their associated side effects. Patients using other topical ophthalmic medications should administer them at least 5 minutes apart from bimatoprost application.
Missed dose
If a dose is missed, the patient should apply the solution at the next scheduled evening application. The patient should not apply a double dose to make up for the missed one. Consistency is key for optimal results, but a single missed dose is unlikely to significantly impact the long-term outcome.
Overdose
Topical overdose of bimatoprost is unlikely to produce life-threatening symptoms. Accidental oral ingestion may cause adverse effects similar to those of other prostaglandin analogs, including headache, nausea, vomiting, dizziness, and diarrhea. In case of accidental ingestion, medical advice should be sought. Topical overdose on the eye or skin may exacerbate known local side effects, such as severe eye irritation, conjunctival hyperemia, or periocular skin pigmentation. The eyes or skin should be rinsed with warm water if excessive application occurs.
Storage
Store the unopened bottle in a refrigerator at 2°C to 8°C (36°F to 46°F). Once the bottle is opened for use, it may be stored at room temperature up to 25°C (77°F) for 6 weeks. Do not freeze. Keep the bottle tightly closed when not in use. Always store in the original container to protect from light. Keep out of the reach and sight of children. Do not use the solution if it has changed color or become cloudy.
Disclaimer
This information is intended for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The efficacy and safety information is based on clinical studies and prescribing information; individual patient experiences may vary.
Reviews
- Clinical Study Data: A multicenter, double-masked, randomized, vehicle-controlled clinical study demonstrated that after 1 month of treatment, 78% of patients taking bimatoprost were deemed by investigators to have improved global eyelash assessment scores versus 18% for vehicle. After 5 months of treatment, bimatoprost-treated patients saw a 25% increase in eyelash length, a 106% increase in thickness/fullness, and a 18% increase in darkness compared to baseline.
- Patient Feedback (Aggregated Themes): Many users report noticeable results beginning after 8-12 weeks of consistent use, with high satisfaction regarding the natural appearance of the enhanced lashes. Common points of feedback include the need for patience during the initial treatment phase and the importance of meticulous application technique to avoid side effects like eyelid darkening. Some users report mild and transient eye redness or itching, particularly upon initiation of therapy.